Photo by 90angle from unsplash
Eosinophilic fasciitis is a rare connective tissue disease of unknown etiology. Therapeutic options include high-dose corticosteroids and other immunosuppressive drugs. We present a typical eosinophilic fasciitis case, which did not… Click to show full abstract
Eosinophilic fasciitis is a rare connective tissue disease of unknown etiology. Therapeutic options include high-dose corticosteroids and other immunosuppressive drugs. We present a typical eosinophilic fasciitis case, which did not respond to first-line treatment, but improved remarkably after infliximab administration. This report demonstrates that in case of initial treatment failure, infliximab might be a relatively safe and effective way of eosinophilic fasciitis management.
Keywords:
fasciitis;
case;
eosinophilic fasciitis;
report;
refractory eosinophilic;
fasciitis successfully
Journal Title: Journal of Scleroderma and Related Disorders
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Scleroderma and Related Disorders
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!